文献速递自身免疫性与大疱性皮肤病

细胞因子和趋化因子测量及其与皮肌炎和临床无肌病性皮肌炎临床严重程度的关联

Measurement of cytokines and chemokines and association with clinical severity of dermatomyositis and clinically amyopathic dermatomyositis.
PubMed 文献 · Br J Dermatol · 2018-10-07

研究纳入40例皮肌炎(DM)或临床无肌病性皮肌炎(CADM)患者,检测血清细胞因子与趋化因子,分析其与皮肤病变活动度及间质性肺病(ILD)的关联。结果显示血清IFN-β和CXCL10与Cutaneous Dermatomyositis Disease Area and Severity Index活动度评分显著相关,IL-6、IL-10、IL-18和IFN-β在急性/亚急性间质性肺炎(A/SIP)患者中显著更高。

要点

  • 血清IFN-β和CXCL10与DM/CADM皮肤病变活动度评分显著相关。
  • 血清IL-6、IL-10、IL-18和IFN-β在A/SIP患者中显著高于无A/SIP者。
  • IL-6和IL-18与抗MDA5抗体血清水平显著相关。

核心结论

  • 血清IFN-β和CXCL10可能是评估DM和CADM患者皮肤疾病活动度的有用生物标志物。
  • 血清IL-6、IL-10、IL-18和IFN-β与A/SIP的发生高度相关。
  • 这些细胞因子可能在DM和CADM的发病机制中发挥作用。

研究设计与样本

  • 收集并分析40例DM或CADM患者的临床特征、实验室检查及血清。
  • 采用酶联免疫吸附试验或流式细胞微珠阵列法检测血清细胞因子和趋化因子。
  • 采用多重非配对t检验比较DM患者与健康对照的细胞因子和趋化因子。
  • 采用Spearman秩相关检验评估血清细胞因子和趋化因子与疾病严重程度的相关性。

主要发现

  • 在DM或CADM患者亚组中,血清IFN-β(rs=0.37,95%CI 0.078-0.62;P=0.019)和CXCL10(rs=0.32,95%CI -0.004至0.57;P=0.045)与Cutaneous Dermatomyositis Disease Area and Severity Index活动度评分显著相关。
  • A/SIP患者血清IL-6、IL-10、IL-18和IFN-β水平显著高于无A/SIP亚组(P<0.05)。
  • IL-6(rs=0.54,95%CI 0.27-0.72;P<0.001)和IL-18(rs=0.46,95%CI 0.21-0.65;P=0.003)与抗黑色素瘤分化相关蛋白5抗体血清水平显著相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Dermatomyositis (DM) is an autoimmune disease affecting primarily the skin, muscle and lung. Dysregulations of cytokines and chemokines are commonly found in inflammatory disorders. OBJECTIVES: To investigate the association between serum cytokines and chemokines and clinical severity, especially cutaneous lesions and interstitial lung disease (ILD) in patients with DM and clinically amyopathic DM (CADM). METHODS: Clinical features, laboratory findings and serum of 40 patients with DM or CADM were collected and analysed. Serum cytokines and chemokines were measured by enzyme-linked immunosorbent assay or cytometric bead array. A multiple unpaired t-test was performed to compare cytokines and chemokines in patients with DM and healthy controls. Correlations of serum cytokines and chemokines with disease severity were evaluated by Spearman's rank correlation test. RESULTS: Serum interferon (IFN)-β [rs = 0·37, 95% confidence interval (CI) 0·078-0·62; P = 0·019] and CXCL10 (rs = 0·32, 95% CI to -0·004 to 0·57; P = 0·045) were significantly correlated with the Cutaneous Dermatomyositis Disease Area and Severity Index activity score in the subset of patients with DM or CADM. Serum levels of interleukin (IL)-6, IL-10, IL-18 and IFN-β were significantly higher in the patients with acute/subacute interstitial pneumonia (A/SIP) than in the subset without A/SIP (P < 0·05). IL-6 (rs = 0·54, 95% CI 0·27-0·72; P < 0·001) and IL-18 (rs = 0·46, 95% CI 0·21-0·65; P = 0·003) were significantly correlated with the serum level of anti-melanoma differentiation-associated protein 5 antibody. CONCLUSIONS: Serum levels of IFN-β and CXCL10 may be useful biomarkers for assessing cutaneous disease activity in patients with DM and CADM. In addition, serum IL-6, IL-10, IL-18 and IFN-β were highly correlated with the occurrence of A/SIP. These cytokines may play a role in the pathogenesis of DM and CADM.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Chen M, Quan C, Diao L, et al. Measurement of cytokines and chemokines and association with clinical severity of dermatomyositis and clinically amyopathic dermatomyositis. Br J Dermatol. 2018. PMID: 30101523. doi:10.1111/bjd.17079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。